Position in XGN
as of Jun 30, 2026
· filed Aug 27, 2026
Position Value
$51,582
+$18,303 QoQ
Shares Held
11,093
0.0% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 57 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in XGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Corient Private Wealth LLC holds $713,680,746 across 27 Diagnostics & Research names. XGN ranks #26 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
707,412 | $354,668,079 | |
| 2 | DHR |
Danaher Corp /De/
|
689,764 | $131,386,246 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
111,488 | $58,691,742 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
26,147 | $33,403,053 | |
| 5 | A |
Agilent Technologies, Inc.
|
240,532 | $31,949,865 | |
| 6 | ICLR |
Icon PLC
|
114,826 | $19,946,424 | |
| 7 | RVTY |
Revvity, Inc.
|
160,410 | $17,847,215 | |
| 8 | ILMN |
Illumina, Inc.
|
95,545 | $16,799,676 |
All Filings in XGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,582 | 11,093 | Shares | Sole | 2026-08-27 | |
| 2026-03-31 | $33,279 | 11,093 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $88,494 | 14,555 | Shares | Sole | 2026-03-09 | |
| 2025-06-30 | $101,593 | 14,555 | Shares | Sole | 2025-09-26 | |
| 2025-03-31 | $52,252 | 14,555 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $45,481 | 11,093 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||